VIOL Future Growth
Future criteria checks 6/6
VIOL is forecast to grow earnings and revenue by 30.6% and 29.1% per annum respectively. EPS is expected to grow by 30.6% per annum. Return on equity is forecast to be 37.1% in 3 years.
Key information
30.6%
Earnings growth rate
30.6%
EPS growth rate
Medical Equipment earnings growth | 31.7% |
Revenue growth rate | 29.1% |
Future return on equity | 37.1% |
Analyst coverage | Good |
Last updated | 23 Jul 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 108,800 | 51,180 | 39,050 | 41,725 | 5 |
12/31/2025 | 85,037 | 40,677 | 36,600 | 38,217 | 7 |
12/31/2024 | 61,760 | 30,695 | 26,380 | 28,650 | 8 |
12/31/2023 | 43,166 | 21,854 | 18,167 | 20,825 | 5 |
3/31/2023 | 35,487 | 14,290 | 14,268 | 14,982 | N/A |
12/31/2022 | 31,108 | 11,473 | 10,699 | 11,229 | N/A |
9/30/2022 | 27,204 | 10,832 | 9,246 | 9,965 | N/A |
6/30/2022 | 24,183 | 7,963 | 8,479 | 9,823 | N/A |
3/31/2022 | 20,728 | 5,451 | 7,168 | 8,640 | N/A |
12/31/2021 | 18,373 | 4,437 | 6,126 | 7,967 | N/A |
9/30/2021 | 14,478 | -3,188 | 4,137 | 5,635 | N/A |
6/30/2021 | 11,723 | -4,334 | 1,750 | 2,443 | N/A |
3/31/2021 | 11,034 | -3,106 | -1,369 | 456 | N/A |
12/31/2020 | 12,154 | -1,811 | -1,875 | -383 | N/A |
12/31/2018 | 6,336 | 781 | 214 | 624 | N/A |
12/31/2017 | 7,123 | 1,924 | 528 | 1,083 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A335890's forecast earnings growth (30.6% per year) is above the savings rate (2.6%).
Earnings vs Market: A335890's earnings (30.6% per year) are forecast to grow faster than the KR market (28.1% per year).
High Growth Earnings: A335890's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A335890's revenue (29.1% per year) is forecast to grow faster than the KR market (9.9% per year).
High Growth Revenue: A335890's revenue (29.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A335890's Return on Equity is forecast to be high in 3 years time (37.1%)